These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27368101)

  • 1. Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.
    Briggs KJ; Koivunen P; Cao S; Backus KM; Olenchock BA; Patel H; Zhang Q; Signoretti S; Gerfen GJ; Richardson AL; Witkiewicz AK; Cravatt BF; Clardy J; Kaelin WG
    Cell; 2016 Jun; 166(1):126-39. PubMed ID: 27368101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGLN1 prolyl hydroxylation of hypoxia-induced transcription factor HIF1α is repressed by SET7-catalyzed lysine methylation.
    Tang J; Deng H; Wang Z; Zha H; Liao Q; Zhu C; Chen X; Sun X; Jia S; Ouyang G; Liu X; Xiao W
    J Biol Chem; 2022 Jun; 298(6):101961. PubMed ID: 35452683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtype.
    Devi U; Singh M; Roy S; Gupta PS; Ansari MN; Saeedan AS; Kaithwas G
    Cell Biochem Funct; 2019 Jun; 37(4):216-227. PubMed ID: 30950543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.
    Strocchi S; Reggiani F; Gobbi G; Ciarrocchi A; Sancisi V
    Oncogene; 2022 Jul; 41(29):3665-3679. PubMed ID: 35705735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
    To KK; Huang LE
    J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
    Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
    Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
    BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma.
    Singh M; Devi U; Roy S; Gupta PS; Saraf SA; Kaithwas G
    Breast Cancer; 2016 Nov; 23(6):820-829. PubMed ID: 26951539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen.
    del Peso L; Castellanos MC; Temes E; Martin-Puig S; Cuevas Y; Olmos G; Landazuri MO
    J Biol Chem; 2003 Dec; 278(49):48690-5. PubMed ID: 14506252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α triggers long-lasting glutamate excitotoxicity via system x
    Hsieh CH; Lin YJ; Chen WL; Huang YC; Chang CW; Cheng FC; Liu RS; Shyu WC
    J Pathol; 2017 Feb; 241(3):337-349. PubMed ID: 27801527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress.
    Jiang W; Zhang M; Gao C; Yan C; Gao R; He Z; Wei X; Xiong J; Ruan Z; Yang Q; Li J; Li Q; Zhong Z; Zhang M; Yuan Q; Hu H; Wang S; Hu MM; Cai C; Wu GS; Jiang C; Zhang YL; Zhang CS; Zhang J
    EMBO J; 2023 Oct; 42(20):e113743. PubMed ID: 37661833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.
    Villar D; Vara-Vega A; Landázuri MO; Del Peso L
    Biochem J; 2007 Dec; 408(2):231-40. PubMed ID: 17725546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation.
    Lee G; Won HS; Lee YM; Choi JW; Oh TI; Jang JH; Choi DK; Lim BO; Kim YJ; Park JW; Puigserver P; Lim JH
    Sci Rep; 2016 Jan; 6():18928. PubMed ID: 26740011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
    Wang F; Yang Y
    Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions.
    Eslavath RK; Sharma D; Bin Omar NAM; Chikati R; Teli MK; Rajanikant GK; Singh SS
    Eur J Pharmacol; 2016 Nov; 791():405-411. PubMed ID: 27393459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1.
    Kato H; Inoue T; Asanoma K; Nishimura C; Matsuda T; Wake N
    Int J Cancer; 2006 Mar; 118(5):1144-53. PubMed ID: 16161047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.